2nd New Product Planning Summit -

2nd New Product Planning Summit
December 7 - 8, 2017
Boston, MA

Develop an effective product development plan to ensure the successful commercialization of new products

Agenda – 2nd New Product Planning Summit



Day One

 Thursday, December 7

8:45AM – 9:00AM

Chairperson’s Opening Remarks


Katja Wachtendonk, Global Director New Products, NOVARTIS

9:00AM – 9:45AM

Optimize the R&D-Commercial Interface to Deliver Drugs of Value to Customers


Lisa Johnson-Pratt, M.D., Head, Early Pipeline Commercial and Oncology Strategy, Global Franchise, GSK

9:45AM – 10:30AM

Making the Target Product Profile (TPP) a Tool and Not a Task to Be Completed


Brad Payne, MBA, Vice President, ARTISAN HEALTHCARE CONSULTING

10:30AM – 11:00AM

Networking Break


11:00AM – 11:45AM

Effectively Manage Product — and People — Transitions From New Product Planning to Launch Teams


Damon Harrell, Senior Director, New Product Planning and Commercialization, ALKERMES

11:45AM – 12:30PM

Strategically Utilize Market Research and Competitive Intelligence to Support Planning and Decision-Making for New Products


David Staknis, Global Health and Life Sciences Practice Lead, FULD + COMPANY

12:30PM – 1:30PM

Luncheon


1:30PM – 2:15PM

Assessing Value and Key Drivers Impacting Commercialization of New Products


Ira Klein, Senior Director of Quality, Strategic Customer Group, JANSSEN

2:15PM – 3:00PM

Creating a Unique Service Model Supporting Patient Acquisition and Retention


Liam Moy, Associate Director – New Product Planning, BIOGEN

3:00PM – 3:30PM

Networking Break


3:30PM – 4:15PM

Interactive Learning Exercise


Elise Brownell, Senior Vice President, Operations and Program Management, AMARANTUS BIOSCIENCE HOLDINGS

4:15PM – 5:00PM

Panel: Explore How the Roles and Responsibilities of New Product Planning Teams Differ Across Therapeutic Areas and Companies


Elise Brownell, Senior Vice President, Operations and Program Management, AMARANTUS BIOSCIENCE HOLDINGS
Sharlene Cirillo, Vice President of Marketing, CHURCHILL PHARMACEUTICALS


Day Two

 Friday, December 8

8:00AM – 9:00AM

Continental Breakfast


9:00AM – 9:15AM

Chairperson’s Recap of Day One


Katja Wachtendonk, Global Director New Products, NOVARTIS

9:15AM – 10:00AM

New Product Positioning: Getting It Right From the Start


Michael P. Bentivegna, Vice President, Commercial Development and Lifecycle Innovation, ZOETIS

10:00AM – 10:45AM

Develop a “Glocal” Marketing Communications Strategy


Kasia Hein-Peters, Vaxelis (PR51) Marketing Head, SANOFI PASTEUR

10:45AM – 11:15AM

Networking Break


11:15AM – 12:00PM

Use Real-World Evidence (RWE) to Enhance the Value Proposition of New Products


Ann Miller, M.D., Vice President, Marketing, SANOFI
Anita Burrell, Adjunct Assistant Professor, Pharmacy Practice and Administration, Ernest Mario School of Pharmacy, RUTGERS UNIVERSITY

12:00PM – 12:45PM

Multidimensional Unmet Needs and Market Shaping—The Critical Role of New Product Planning


Robert Haesemeyer, Director, New Product Planning, PURDUE PHARMA

12:45PM – 1:45PM

Luncheon


1:45PM – 2:30PM

Build a Business Case for New Product Concepts in a Small Company Environment


Tony Russell, Senior Director, Product Strategy and Commercial Planning, THERAVANCE BIOPHARMA

2:30PM – 3:15PM

New Product Planning and Market Interface


Gary Pyner, Chief Commercial Officer, ASKLEPION PHARMACEUTICALS

3:15PM – 3:30PM

Chairperson’s Closing Remarks


Katja Wachtendonk, Global Director New Products, NOVARTIS


live chat software